Hyperamylasemia in response to ritodrine or ephedrine administered to pregnant women.

@article{Takahashi1997HyperamylasemiaIR,
  title={Hyperamylasemia in response to ritodrine or ephedrine administered to pregnant women.},
  author={Toshifumi Takahashi and Hisanori Minakami and Tsutomu Tamada and Ikuo Sato},
  journal={Journal of the American College of Surgeons},
  year={1997},
  volume={184 1},
  pages={31-6}
}
BACKGROUND Ritodrine and ephedrine can induce hyperamylasemia in pregnant women. The incidence of these beta-agonist-induced hyperamylasemias and their interaction on serum amylase activity are not known. STUDY DESIGN Serum amylase activity was determined 12 to 24 hours after the administration of ritodrine alone (n = 140), ephedrine alone (n = 160), ephedrine and ritodrine simultaneously (n = 34), and ephedrine after prolonged (> or = 7 days) use of ritodrine (n = 101). RESULTS A… CONTINUE READING